Literature DB >> 16081996

Phenotypic and genotypic mupirocin resistance among Staphylococci causing prosthetic joint infection.

Margalida Rotger1, Andrej Trampuz, Kerryl E Piper, James M Steckelberg, Robin Patel.   

Abstract

Mupirocin MICs and mupA presence were determined in 108 staphylococci causing prosthetic joint infection. Zero of 35 isolates (0%) of methicillin-susceptible Staphylococcus aureus, 4/15 (27%) methicillin-resistant S. aureus isolates, 3/16 (19%) methicillin-susceptible coagulase-negative staphylococci, and 11/42 (26%) methicillin-resistant coagulase-negative staphylococci were mupirocin resistant. mupA was detected in all five high-level mupirocin-resistant staphylococci and one mupirocin-susceptible staphylococcus.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16081996      PMCID： PMC1234000          DOI： 10.1128/JCM.43.8.4266-4268.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  26 in total

1.  Characterization of the mupA gene in strains of methicillin-resistant Staphylococcus aureus with a low level of resistance to mupirocin.

Authors:  S Fujimura; A Watanabe; D Beighton
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery.

Authors:  M D Kalmeijer; E van Nieuwland-Bollen; D Bogaers-Hofman; G A de Baere
Journal:  Infect Control Hosp Epidemiol       Date:  2000-05       Impact factor: 3.254

3.  First report of clinical and microbiological failure in the eradication of glycopeptide-intermediate methicillin-resistant Staphylococcus aureus carriage by mupirocin.

Authors:  J W Decousser; P Pina; J C Ghnassia; J P Bedos; P Y Allouch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-08       Impact factor: 3.267

4.  Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

Authors:  C von Eiff; K Becker; K Machka; H Stammer; G Peters
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

5.  Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus.

Authors:  S Harbarth; S Dharan; N Liassine; P Herrault; R Auckenthaler; D Pittet
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

6.  Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital.

Authors:  Hee-Jeong Yun; Sang Won Lee; Gyu Man Yoon; Su Yeon Kim; Sooyoung Choi; Yeong Seon Lee; Eung-Chil Choi; Sunghoon Kim
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

7.  Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections.

Authors:  M H Wilcox; J Hall; H Pike; P A Templeton; W N Fawley; P Parnell; P Verity
Journal:  J Hosp Infect       Date:  2003-07       Impact factor: 3.926

8.  Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?

Authors:  Elaine S Walker; Jose E Vasquez; Roy Dula; Hollie Bullock; Felix A Sarubbi
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

Review 9.  Molecular and antibiofilm approaches to prosthetic joint infection.

Authors:  Andrej Trampuz; Douglas R Osmon; Arlen D Hanssen; James M Steckelberg; Robin Patel
Journal:  Clin Orthop Relat Res       Date:  2003-09       Impact factor: 4.176

10.  The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.

Authors:  F J Schmitz; E Lindenlauf; B Hofmann; A C Fluit; J Verhoef; H P Heinz; M E Jones
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790
View more
  5 in total

1.  Antimicrobial resistance and presence of ileS-2 gene encoding mupirocin resistance in clinical isolates of methicillin-resistant Staphylococcus sp.

Authors:  E Szczuka; A Kaznowski; K Bosacka; E Strzemieczna
Journal:  Folia Microbiol (Praha)       Date:  2009-05-06       Impact factor: 2.099

2.  High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population.

Authors:  Nina K Antonov; Maria C Garzon; Kimberly D Morel; Susan Whittier; Paul J Planet; Christine T Lauren
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

3.  Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States.

Authors:  Adriana Cadilla; Michael Z David; Robert S Daum; Susan Boyle-Vavra
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

4.  Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.

Authors:  Andrew E Simor; Tammy L Stuart; Lisa Louie; Christine Watt; Marianne Ofner-Agostini; Denise Gravel; Michael Mulvey; Mark Loeb; Allison McGeer; Elizabeth Bryce; Anne Matlow
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

5.  Staphylococcus epidermidis isolates from nares and prosthetic joint infections are mupirocin susceptible.

Authors:  Lavin Salih; Staffan Tevell; Emeli Månsson; Åsa Nilsdotter-Augustinsson; Bengt Hellmark; Bo Söderquist
Journal:  J Bone Jt Infect       Date:  2018-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.